Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity
Open Access
- 1 July 2016
- journal article
- Published by Elsevier in Cell Reports
- Vol. 16 (2) , 508-519
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01DK058398, RO1DK078184)
- Fundação para a Ciência e a Tecnologia (SFRH/BD/44294/2008)
This publication has 49 references indexed in Scilit:
- Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent ExpressionCell Metabolism, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Yin Yang 1 Deficiency in Skeletal Muscle Protects against Rapamycin-Induced Diabetic-like Symptoms through Activation of Insulin/IGF SignalingCell Metabolism, 2012
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2011
- Hormonal Regulation of Hepatic Glucose Production in Health and DiseaseCell Metabolism, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent modelJournal of Hepatology, 2010
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesisProceedings of the National Academy of Sciences, 2010
- High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial functionin vivoBiochemical Journal, 2008
- Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistanceProceedings of the National Academy of Sciences, 2007